Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

McKesson (MCK) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareMedical DistributionMCK

Closing price · Nov 19, 2026 $1,058.38 -2.4% on the day · +24.6% over 12 months 52-week range $723.60 – $1,105.04
Get MCK alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling8last 12 months
Reported sales$30.1M19 of 21 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.

Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Feb 3, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale Francisco Fraga, CTO sold 650 shares at $1,102.96 ($717K).

Trade date
Nov 5, 2026
Disclosed to the SEC
Nov 6, 2026
Type
Pre-planned sale, 10b5-1 (code S)

Read the original SEC filing ↗All MCK insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

MCK insider transactions (Form 4)

Open-market purchases and sales. 67 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Nov 6SEC Francisco FragaCTO Sell Plan 6504,414 held (−13%) $1,102.96 $717K -4.0% —
Nov 5SEC Francisco FragaCTO Sell Plan 6005,064 held (−11%) $1,050.00 $630K +0.8% —
Oct 19SEC Francisco FragaCTO Sell Plan 8005,423 held (−13%) $995.80 $797K +6.3% —
Sep 10SEC Napoleon B. Rutledge Jr.Svp, Controller & Cao Sell Plan 111521 held (−18%) $891.45 $99K +18.7% —
Aug 11SEC Bradley E. LermanDirector Sell 301 $892.33 $269K +18.6% —
Jul 8SEC Brian S. TylerCEO Sell Plan 8,4635,919 held (−59%) $793.56 $6.7M +33.4% —
Jun 18SEC Brian S. TylerCEO Sell Plan 8,46314,382 held (−37%) $775.13 $6.6M +36.5% —
Jun 11SEC Brian S. TylerCEO Sell Plan 4,92922,845 held (−18%) $763.00 $3.8M +38.7% —
Jun 8SEC Napoleon B. Rutledge Jr.Svp, Controller & Cao Sell Plan 133632 held (−17%) $764.00 $102K +38.5% —
Jun 3SEC Thomas L. RodgersEvp, Chief Strategy & Bdo Sell Plan 6992,268 held (−24%) $735.27 $514K +43.9% —
Jun 3SEC Thomas L. RodgersEvp, Chief Strategy & Bdo Sell Plan 1232,967 held (−4%) $735.50 $90K +43.9% —
Jun 2SEC Leann B. SmithEvp & Chief Hr Officer Sell Plan 1,8104,798 held (−27%) $735.50 $1.3M +43.9% —
May 27SEC Michele LauGeneral Counsel Sell Plan 3,5503,247 held (−52%) $761.09 $2.7M +39.1% —
May 27SEC Thomas L. RodgersEvp, Chief Strategy & Bdo Sell Plan 2,3883,090 held (−44%) $761.09 $1.8M +39.1% —
Mar 4SEC Michele LauGeneral Counsel Sell Plan 2,7253,247 held (−46%) $990.00 $2.7M +6.9% —
Feb 23SEC Maria MartinezDirector Sell 349301 held (−54%) $939.87 $328K +12.6% —
Feb 18SEC Leann B. SmithEvp & Chief Hr Officer Sell Plan 1902,989 held (−6%) $945.00 $180K +12.0% —
Feb 13SEC Michele LauGeneral Counsel Sell Plan 3035,972 held (−5%) $933.39 $283K +13.4% —
Feb 9SEC Napoleon B. Rutledge Jr.Svp, Controller & Cao Sell Plan 328 $955.00 $313K +10.8% —
Jan 6SEC Thomas L. RodgersEvp, Chief Strategy & Bdo Sell Plan 2762,268 held (−11%) $816.18 $225K +29.7% —
Nov 10SEC Napoleon B. Rutledge Jr.Svp, Controller & Cao Sell Plan 329328 held (−50%) $861.63 $283K +22.8% —
Historical context

Similar past setups: not applicable. MCK has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with MCK in the Research Lab

MCK has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

MCK closeInsider buyInsider sale
6008001,0001,200DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-04EEarnings release filed 2026-05-07EEarnings release filed 2026-08-05EEarnings release filed 2026-11-04Sold $98,951 on 2026-09-08 · Napoleon B. Rutledge Jr.Sold $101,612 on 2026-06-05 · Napoleon B. Rutledge Jr.Sold $179,550 on 2026-02-17 · Leann B. SmithSold $225,266 on 2026-01-05 · Thomas L. RodgersSold $268,590 on 2026-08-10 · Bradley E. LermanSold $282,817 on 2026-02-11 · Michele LauSold $313,240 on 2026-02-06 · Napoleon B. Rutledge Jr.Sold $328,013 on 2026-02-19 · Maria MartinezSold $513,954 on 2026-06-02 · Thomas L. RodgersSold $630,000 on 2026-11-04 · Francisco FragaSold $716,924 on 2026-11-05 · Francisco FragaSold $797,129 on 2026-10-15 · Francisco FragaSold $1,421,722 on 2026-06-01 · Leann B. Smith, Thomas L. RodgersSold $2,697,750 on 2026-03-02 · Michele LauSold $3,760,827 on 2026-06-09 · Brian S. TylerSold $4,519,352 on 2026-05-26 · Michele Lau, Thomas L. RodgersSold $6,559,925 on 2026-06-17 · Brian S. TylerSold $6,715,898 on 2026-07-07 · Brian S. Tyler
Bought, 12 months$0
Sold, 12 months$30.1M
Insiders buying0
Insiders selling8

McKesson insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 8 sold $30.1M of MCK stock on the open market; P/E 24.5 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

MCK insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $283K sold (1 trades)Q4 2025Q1 2026: $4.0M sold (6 trades)Q1 2026Q2 2026: $16.9M sold (8 trades)Q2 2026Q3 2026: $7.1M sold (3 trades)Q3 2026Q4 2026: $2.1M sold (3 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$2.1M3
Q3 2026—0$7.1M3
Q2 2026—0$16.9M8
Q1 2026—0$4.0M6
Q4 2025—0$283K1

Valuation, profit and volume

P/E (trailing)24.5Sector median 25.0
Market value$106.73BMedical Distribution
Profit margin1.1%Revenue growth +7.7%
Volume vs. 50-day0.8×Last 5 sessions

Source: Yahoo Finance, as of Oct 5, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 McKesson insiders reported open-market purchases totaling $0, while 8 insiders reported sales totaling $30.1M. 19 of 21 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

MCK earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Nov 4, 2026 -1.1% Sold $797K +7.2%S&P -2.8% pending
Aug 5, 2026 -0.1% Sold $6.7M +4.9%S&P -0.4% +4.3%
May 7, 2026 -11.7% None -1.0%S&P +0.5% +5.5%
Feb 4, 2026 +1.3% Sold $225K +12.5%S&P -1.7% -3.9%
Nov 5, 2025 +6.8% None +2.0%S&P -0.7% -5.7%
Sep 18, 2025 +0.1% None +0.9%S&P +1.0% +12.6%
Aug 6, 2025 -0.2% None -6.5%S&P +0.7% +3.8%
May 8, 2025 +3.9% None -4.0%S&P +0.6% +2.9%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

MCK short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 43% of volume sold short2026-08-27: 71% of volume sold short2026-08-28: 68% of volume sold short2026-08-31: 72% of volume sold short2026-09-01: 57% of volume sold short2026-09-02: 51% of volume sold short2026-09-03: 47% of volume sold short2026-09-04: 70% of volume sold short2026-09-08: 62% of volume sold short2026-09-09: 59% of volume sold short2026-09-10: 43% of volume sold short2026-09-11: 63% of volume sold short2026-09-14: 77% of volume sold short2026-09-15: 70% of volume sold short2026-09-16: 71% of volume sold short2026-09-17: 70% of volume sold short2026-09-18: 72% of volume sold short2026-09-21: 60% of volume sold short2026-09-22: 58% of volume sold short2026-09-23: 53% of volume sold short2026-09-24: 42% of volume sold short2026-09-25: 48% of volume sold short2026-09-28: 45% of volume sold short2026-09-29: 50% of volume sold short2026-09-30: 44% of volume sold short2026-10-01: 65% of volume sold short2026-10-02: 59% of volume sold short2026-10-05: 54% of volume sold short2026-10-06: 58% of volume sold short2026-10-07: 39% of volume sold short2026-10-08: 56% of volume sold short2026-10-09: 61% of volume sold short2026-10-12: 62% of volume sold short2026-10-13: 49% of volume sold short2026-10-14: 46% of volume sold short2026-10-15: 44% of volume sold short2026-10-16: 54% of volume sold short2026-10-19: 48% of volume sold short2026-10-20: 51% of volume sold short2026-10-21: 39% of volume sold short2026-10-22: 32% of volume sold short2026-10-23: 52% of volume sold short2026-10-26: 27% of volume sold short2026-10-27: 45% of volume sold short2026-10-28: 26% of volume sold short2026-10-29: 43% of volume sold short2026-10-30: 47% of volume sold short2026-11-02: 47% of volume sold short2026-11-03: 33% of volume sold short2026-11-04: 49% of volume sold short2026-11-05: 46% of volume sold short2026-11-06: 58% of volume sold short2026-11-09: 32% of volume sold short2026-11-10: 40% of volume sold short2026-11-11: 39% of volume sold short2026-11-12: 41% of volume sold short2026-11-13: 52% of volume sold short2026-11-16: 47% of volume sold short2026-11-17: 53% of volume sold short2026-11-18: 58% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 58%20-day average: 44%Prior 2 months: 56%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded MCK

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 +23.3%
Markwayne MullinSenate Bought $15,001 - $50,000 Feb 4, 2026Mar 2, 2026 +29.1%
Markwayne MullinSenate Bought $15,001 - $50,000 Jan 5, 2026Feb 4, 2026 +28.7%
Markwayne MullinSenate Bought $15,001 - $50,000 Jan 5, 2026Feb 4, 2026 +28.7%

Insiders at McKesson

InsiderBoughtSoldLast filingPast buys beat S&PScore
Brian S. TylerCEO — $17.0M Jul 8, 2026 — —
Michele LauGeneral Counsel — $5.7M May 27, 2026 — —
Thomas L. RodgersEvp, Chief Strategy & Bdo — $2.6M Jun 3, 2026 — —
Francisco FragaCTO — $2.1M Nov 6, 2026 — —
Leann B. SmithEvp & Chief Hr Officer — $1.5M Jun 2, 2026 — —
Napoleon B. Rutledge Jr.Svp, Controller & Cao — $797K Sep 10, 2026 — —
Maria MartinezDirector — $328K Jul 23, 2026 — —
Bradley E. LermanDirector — $269K Aug 11, 2026 — —
Dominic J. CarusoDirector — — Jul 23, 2026 — —
Kathleen Wilson-ThompsonDirector — — Jul 23, 2026 — —
Britt J. VitaloneCFO — — May 27, 2026 — —

Board links: companies that share insiders with MCK

Directors and executives who filed Form 4s for MCK and another company in the last 12 months.

See the map →
  • ALGNAlign Technology Britt J. Vitalone CFO here · Director at ALGN · latest filing May 27, 2026
  • BACBank of America Maria Martinez Director here · Director at BAC · latest filing Jul 23, 2026
  • RSGRepublic Services Brian S. Tyler CEO here · Director at RSG · latest filing Jul 8, 2026
  • SBUXStarbucks Bradley E. Lerman Director here · General Counsel at SBUX · latest filing Aug 11, 2026
  • TSLATesla Kathleen Wilson-Thompson Director here · Director at TSLA · latest filing Jul 23, 2026
  • TSNTyson Foods Maria Martinez Director here · Director at TSN · latest filing Jul 23, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

MCK stock: common questions

Are McKesson insiders buying MCK stock?

No. No McKesson insider reported an open-market purchase of MCK in the past 12 months.

Are McKesson insiders selling MCK stock?

8 insiders reported sales worth $30.1M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is MCK's P/E ratio?

MCK trades at about 24.5 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is MCK's 52-week range?

Over the past year MCK has traded between $723.60 and $1,105.04. It last closed at $1,058.38 on Nov 19, 2026.